Wellington Management Group’s BioNTech BNTX Stock Holding History

Wellington Management Group’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.1M	Sell	130,334 -4,684	-3%	-$441K	﹤0.01%	1239
2026 Q1	$12M	Buy	135,018 +121,951	+933%	+$12.5M	﹤0.01%	1198
2025 Q4	$1.24M	Buy	+13,067	New	+$1.32M	﹤0.01%	1680
2022 Q2	–	Sell	-176,515	Closed	-$30.1M	–	2082
2022 Q1	$30.1M	Sell	176,515 -31	-0%	-$5.21K	0.01%	910
2021 Q4	$45.5M	Buy	+176,546	New	+$48.4M	0.01%	859
2021 Q2	–	Sell	-366,030	Closed	-$40M	–	2139
2021 Q1	$40M	Sell	366,030 -33,362	-8%	-$3.54M	0.01%	871
2020 Q4	$32.6M	Sell	399,392 -174,912	-30%	-$17.2M	0.01%	908
2020 Q3	$39.8M	Sell	574,304 -22,908	-4%	-$1.64M	0.01%	759
2020 Q2	$39.9M	Buy	+597,212	New	+$29.8M	0.01%	753

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Wellington Management Group's BNTX Position: Q2 2026 in Review

Wellington Management Group reduced its BioNTech (BNTX) stake by 3.5% in Q2 2026, selling an estimated $441K and leaving 130,334 shares worth $12.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

Wellington Management Group first reported a position in BNTX in Q2 2020 and has held it in 9 quarters since. The position peaked at $45.5M in Q4 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Wellington Management Group held 130,334 shares of BioNTech worth $12.1M as of Q2 2026.
Wellington Management Group sold 4,684 BioNTech shares in Q2 2026, an estimated $441K.
BioNTech made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1239 holding.
Wellington Management Group first reported a position in BioNTech in Q2 2020 and has held it in 9 quarters since.
Wellington Management Group's BioNTech position peaked at $45.5M in Q4 2021.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.